title: Progenitor cells in arteriosclerosis: good or bad guys?
abstract: Accumulating evidence indicates that the mobilization and recruitment of circulating or tissue-resident progenitor cells that give rise to endothelial cells (ECs) and smooth muscle cells (SMCs) can participate in atherosclerosis, neointima hyperplasia after arterial injury, and transplant arteriosclerosis. It is believed that endothelial progenitor cells do exist and can repair and rejuvenate the arteries under physiologic conditions; however, they may also contribute to lesion formation by influencing plaque stability in advanced atherosclerotic plaque under specific pathologic conditions. At the same time, smooth muscle progenitors, despite their capacity to expedite lesion formation during restenosis, may serve to promote atherosclerotic plaque stabilization by producing extracellular matrix proteins. This profound evidence provides support to the hypothesis that both endothelial and smooth muscle progenitors may act as a double-edged sword in the pathogenesis of arteriosclerosis. Therefore, the understanding of the regulatory networks that control endothelial and smooth muscle progenitor differentiation is undoubtedly fundamental both for basic research and for improving current therapeutic avenues for atherosclerosis. We update the progress in progenitor cell study related to the development of arteriosclerosis, focusing specifically on the role of progenitor cells in lesion formation and discuss the controversial issues that regard the origins, frequency, and impact of the progenitors in the disease.
authors.affiliation: Cardiovascular Division, King's College London BHF Centre, London, England.
authors.forename: Paola
authors.initials: P
authors.lastname: Campagnolo
authors.forename: Mei Mei
authors.initials: MM
authors.lastname: Wong
authors.forename: Qingbo
authors.initials: Q
authors.lastname: Xu
mesh_terms: D000818:Animals; D001161:Arteriosclerosis / Q000473:pathology*; D001854:Bone Marrow Cells / Q000473:pathology; D042783:Endothelial Cells / Q000473:pathology*; D006801:Humans; D006965:Hyperplasia / Q000473:pathology; D051379:Mice; D032389:Myocytes, Smooth Muscle / Q000473:pathology*; D058426:Neointima / Q000473:pathology; D009389:Neovascularization, Pathologic / Q000473:pathology; D033581:Stem Cell Transplantation / Q000009:adverse effects*; D013234:Stem Cells / Q000473:pathology*